Case 1: Influenza Vaccination in an 11-Year-Old Boy Coming in for a Well Check

Program Description:

School-aged children are at high risk for acquiring influenza and are the primary transmission vectors of influenza to the community. To optimize immunization rates among these youngsters, practitioners need to be aware of the current recommendations, who is at particular risk for disease, and which of the available vaccines is preferred for a particular child. This case highlights the importance of addressing the parent’s concerns about safety as well as

For the Influenza Resource Center, please click here.

Media:

INTENDED AUDIENCE:

This activity has been designed to meet the educational needs of pediatricians, pediatric nurse practitioners, pediatric clinical nurse specialists, registered nurses, pediatric office-based registered nurses, and pediatric physician assistants.

Activity Objectives:

After taking part in this educational activity, participants should be better able to:

• Describe the incidence and burden of pediatric influenza infection
• Employ current recommendations for influenza vaccination in pediatric patients
• Evaluate the benefits and limitations of the live attenuated influenza vaccine (LAIV) and the trivalent inactivated influenza vaccine (TIV)
• Implement strategies to improve parent education about common misconceptions about influenza vaccination
• For Registered Nurses: Provide appropriate care and counsel for patients and their families
  
  

  Credits	Type	Accreditation Statement	Designation Statement
  0.50	AMA PRA Category 1 Credit(s)TM	This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Haymarket Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.	The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  0.70	CE for Nurses	Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.	This educational activity for 0.70 contact hours is provided by Postgraduate Institute for Medicine.

  Faculty:

  Joseph B. Domachowske, MD, Chair
  Professor of Pediatrics, Microbiology and Immunology
  State University of New York Upstate Medical University
  College of Medicine
  Syracuse, New York

  Disclosures:

  Disclosure of Conflicts of Interest
  Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
  
  The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
  
  Joseph B. Domachowske, MD, hereby states that he receives fees for non-CME/CE services from GlaxoSmithKline, Merck & Co, MedImmune, LLC, Novartis Pharmaceuticals Corporation, and Sanofi.
  
  Concettina Tolomeo, DNP, APRN, FNP-BC, AE-C (CE Reviewer), hereby states that she receives consulting fees from WellTok Inc.
  
  The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
  
  The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP; Jan Schultz, RN, MSN, CCMEP; and Patricia Staples, MSN, NP-C, CCRN, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
  
  The following Haymarket Medical Education planners and managers hereby state the following financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months: Mary Jo Krey, Senior Project Editor, Lori Marrese, Senior Program Manager, and Marian Freedman, medical writer, have no real or apparent conflicts of interest to report.
  
  Disclosure of Unlabeled Use
  This educational activity may contain discussion of unapproved and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine, MedImmune, LLC, and Haymarket Medical Education, do not recommend the use of any agent outside of the labeled indications.
  
  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Institute for Medicine, MedImmune, LLC, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
  
  Disclaimer
  Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
  
  Jointly sponsored by Postgraduate Institute for Medicine and Haymarket Medical Education.
  
                   
  
  
  If you have any questions relating to the accreditation of this activity, please contact information@pimed.com.
  
  This activity is supported by an educational grant from MedImmune, LLC.
  
  

  Instructions:

  There are no fees for participating and receiving CME/CE credit for this activity. During the period February 28, 2012 through February 28, 2013, participants must read the learning objectives and faculty disclosures and study the educational activity.
  
  To obtain credit, a score of 70% or better is required. This CME/CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
  
  Privacy Policy
  To view the myCME privacy policy, please click here.
  
  To view the Postgraduate Institute for Medicine privacy policy, please click here.

  SYSTEM REQUIREMENTS:

  WINDOWS PC SYSTEM REQUIREMENTS:
  266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
  
  MACINTOSH^® SYSTEM REQUIREMENTS:
  Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20 MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands of Colors”; Macromedia Flash Player 6 or higher.